Rapid simultaneous determination of indacaterol maleate and glycopyrronium bromide in inhaler capsules using a validated stability-indicating monolithic LC method

Table 3 Determination of IND and GLY in commercial inhaler capsules

Formulation	Labelled amount		Mean found		Recovery^a (%)
Formulation	IND	GLY	IND	GLY	IND	GLY
Ultibro^® Breezhaler^®	110	50	110.73	50.58	100.67 ± 0.35	101.16 ± 0.47
Onbrez Breezhaler^®	150	–	150.54	–	100.36 ± 0.26	–
Seebri^® Breezhaler^®	–	50	–	50.25	–	100.49 ± 0.56

ISSN: 2661-801X